SNSE
Sensei Biotherapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$13.85
−22.28%Margins
Gross margin
2740.8%
EBITDA margin
3799.3%
EBIT margin
3826.9%
Net margin
3802.5%
FCF margin
497.1%
-96.5%
Return on equity
-89.8%
Return on assets
-96.6%
Return on invested capital
-0.04x
Asset turnover
-$24.1M
Cash from operations
$151
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026